The demographic shift is equally compelling: 40% of aesthetic patients in 2024 were first-time users, with Gen Z representation nearly tripling since 2017 to comprise 10% of the aesthetic clientele.3 This expansion represents a fundamental market enlargement rather than mere category switching, with 63% of facial aesthetic seekers having no prior engagement with medical aesthetics services.4 The Science Behind "GLP-1 Face": Understanding the Biological Mechanisms Molecular Impact on Skin Architecture Clinical research reveals that GLP-1 receptor agonists exert direct effects on skin physiology beyond weight loss-induced changes
Your healthcare provider may suggest an individualized approach to dose reduction based on your specific circumstances
Horm Metab Res (1995) 27(8):3725
To find out more about the formulation, how biotic solutions are becoming the cornerstone of the weight management scene and the molecular mechanisms underlying the nutraceuticals efficacy, NBR caught up with resbiotics founder and CEO, Dr Vivek Lal
The CV outcome trial (CVOT) with dapagliflozin (DECLARE-TIMI 58), which included two thirds of participants without established atherosclerotic CV disease (ASCVD) (i.e
AC has been reported to have antitumor properties in pulmonary A549 cancer cells